PL2457576T3 - Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji - Google Patents

Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji

Info

Publication number
PL2457576T3
PL2457576T3 PL10460047T PL10460047T PL2457576T3 PL 2457576 T3 PL2457576 T3 PL 2457576T3 PL 10460047 T PL10460047 T PL 10460047T PL 10460047 T PL10460047 T PL 10460047T PL 2457576 T3 PL2457576 T3 PL 2457576T3
Authority
PL
Poland
Prior art keywords
infections
medical
treatment
metabolic syndrome
lactobacillus reuteri
Prior art date
Application number
PL10460047T
Other languages
English (en)
Inventor
Danuta Kruszewska
Original Assignee
Eurochit Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurochit Danuta Kruszewska filed Critical Eurochit Danuta Kruszewska
Publication of PL2457576T3 publication Critical patent/PL2457576T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10460047T 2010-11-29 2010-11-29 Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji PL2457576T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10460047.3A EP2457576B1 (en) 2010-11-29 2010-11-29 Lactobacillus reuteri strain for use in the medical and veterinary prophylaxis and treatment of metabolic syndrome or infections

Publications (1)

Publication Number Publication Date
PL2457576T3 true PL2457576T3 (pl) 2021-04-06

Family

ID=43901014

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10460047T PL2457576T3 (pl) 2010-11-29 2010-11-29 Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji

Country Status (2)

Country Link
EP (1) EP2457576B1 (pl)
PL (1) PL2457576T3 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150027152A (ko) * 2012-05-29 2015-03-11 다누타 크루셰프스카 인간 및 동물 모두에서 예방 및 의약에 유용한 락토바실러스 류테리 ｄａｎ080을 포함하는 나노프로덕트 및 이의 의학적 용도
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
WO2016002757A1 (ja) * 2014-06-30 2016-01-07 株式会社明治 プリン体吸収を抑制する乳酸菌及びその用途
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9636368B2 (en) 2014-08-22 2017-05-02 Food Industry Research And Development Institute Strain of Lactobacillus rhamnosus and its metabolites for use in inhibiting xanthine oxidase and treating gout
WO2018045534A1 (zh) * 2016-09-08 2018-03-15 潍坊华英生物科技有限公司 一种增强免疫功能的静脉注射剂
CN111388509A (zh) 2019-01-03 2020-07-10 丰华生物科技股份有限公司 用于降低血中尿酸浓度的乳酸菌菌株的食品组合物以及医药组合物
TWI719691B (zh) * 2019-10-28 2021-02-21 葡萄王生技股份有限公司 羅伊氏乳桿菌（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｅｕｔｅｒｉ）菌株ＧＫＲ１用於製備降低尿酸之組成物的用途
CN114717127B (zh) * 2021-03-31 2023-08-29 青岛蔚蓝生物股份有限公司 一株具有预防和缓解过敏性哮喘症状的罗伊氏乳杆菌及其应用
CN116585362B (zh) * 2023-06-02 2024-09-17 江西仁仁健康微生态科技有限公司 罗伊氏粘液乳杆菌hcs02-001降尿酸应用及产品
CN118460435B (zh) * 2024-07-09 2024-10-08 中国农业科学院饲料研究所 罗伊氏乳杆菌及其作为饲料添加剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008450A1 (en) 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
EP0380484B1 (en) 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
KR101450511B1 (ko) * 2007-11-29 2014-10-15 가부시키가이샤 메이지 혈중 요산치 저감작용을 갖는 유산균

Also Published As

Publication number Publication date
EP2457576A1 (en) 2012-05-30
EP2457576B1 (en) 2020-07-08

Similar Documents

Publication Publication Date Title
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
HUE060892T2 (hu) Probiotikus baktériumtörzsek a szájüreg betegségeinek megelõzésére és kezelésére
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
IL216582A0 (en) Composition for use in decreasing the transmission of human pathogens, devices comprising the same and uses thereof
PL2996700T3 (pl) Kompozycja zawierająca bakterie kwasu mlekowego do stosowania w zapobieganiu i/lub leczeniu zakażeń i/lub stanów zapalnych dróg moczowych i/lub pęcherza moczowego
PL2364712T3 (pl) Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie
EP2943210B8 (en) Lactobacillus fermentum me-3 for use in treating metabolic syndrome related diseases
IL222333A0 (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
PL2457575T3 (pl) Nowy sposób uzyskania szczepu Lactobacillus reuteri przydatnego w profilaktyce oraz w leczeniu w medycynie ludzkiej i weterynarii
HUE042643T2 (hu) Lactobacillus reuteri ATCC PTA 6475 csontveszteség
PT2575971E (pt) Extratos combinados de plantas para utilização no tratamento de infeções microbianas
PL2854910T3 (pl) Poziomy ceramidu w leczeniu i zapobieganiu infekcjom
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL241113A0 (en) Methods for treating infections in overweight or obese patients by using antibiotics
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
SG11201405778WA (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
GB2483313B (en) Use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis
HUE038120T2 (hu) Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
PL2374461T3 (pl) Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką
SI2699545T1 (sl) Novi amino-pirolinski derivati in uporaba le-teh pri preprečevanju in/ali zdravljenju metaboličnega sindroma
IL219444A (en) Procine for use in the treatment of blood cell infections
HU1000356D0 (en) Quinoxaline derivatives and their use for the treatment of mycobacterial infections
PT2389936E (pt) Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca
PT2706994T (pt) Composição farmacêutica tópica para utilização no tratamento e/ou na prevenção de infeções de lesões cutâneas